The Claim
In individuals with Down syndrome and autoimmune thyroid disease, the absence of thyroid-stimulation blocking antibody (TSBAb) does not prevent the development of hypothyroidism when thyroid-stimulating antibody (TSAb) is present, challenging the assumption that TSBAb is necessary for hypothyroidism in autoimmune thyroid disease.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with Down syndrome and autoimmune thyroid disease, hypothyroidism can occur even when the thyroid-stimulation blocking antibody is absent, as long as the thyroid-stimulating antibody is present, indicating that the blocking antibody is not required for hypothyroidism to develop.
See the scientific wording
In individuals with Down syndrome and autoimmune thyroid disease, the absence of thyroid-stimulation blocking antibody (TSBAb) does not preclude the development of hypothyroidism, even in the presence of thyroid-stimulating antibody (TSAb), challenging the assumption that TSBAb is necessary for hypothyroidism in autoimmune thyroid disease.
Long-term immune attack on the thyroid destroys its hormone-producing cells, so even when antibodies try to force the thyroid to make more hormones, the damaged cells cannot respond and the thyroid keeps producing too little hormone.
What the research says
1 studyEven when the body has antibodies that usually make the thyroid overactive and no antibodies that block it, people with Down syndrome can still end up with an underactive thyroid — meaning blocking antibodies aren't the only way to get hypothyroidism.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.